Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin lambda variable 3-15 (IGLV3-15) is classified as a pseudogene within the immunoglobulin lambda variable gene family, located on chromosome 22q11.2. Pseudogenes like IGLV3-15 are genomic sequences similar to functional genes but are generally non-functional and do not produce active protein products. The immunoglobulin lambda variable gene family encodes the variable regions of immunoglobulin light chains, which are critical for antigen recognition and adaptive immune responses, but IGLV3-15 itself does not encode a functional immunoglobulin domain due to its pseudogene status. IGLV3-15 is consistently listed as a pseudogene in major gene databases and references, indicated by sources such as Sigma-Aldrich, BioGPS, VarSome, and Merck Millipore. Pseudogenes do not encode functional proteins and thus are not considered therapeutic targets, diagnostic biomarkers, or direct participants in disease pathways. No evidence supports its use as a drug target or clinical biomarker; it does not interact with drugs or have a known mechanism of therapeutic action. The presence of this gene in nomenclature tables and genetic maps (e.g., IMGT) is for genomic annotation and does not imply functional significance. The aliases listed are alternate gene symbol forms or legacy nomenclature. There is nothing to suggest this entry is misspelled or a non-existent gene; however, it is important to note it is a pseudogene and not a functional protein-coding gene, so using it as a target is scientifically incorrect.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin lambda variable 3-15 (pseudogene) (IGLV3-15).